PR
Therapeutic Areas
Molecure Pipeline
| Drug | Indication | Phase |
|---|---|---|
| OATD-01 | Idiopathic Pulmonary Fibrosis (IPF) | Phase II |
| OATD-02 | Oncology (Solid Tumors) | Phase I |
| RNA Platform Programs | Undisclosed Oncology Targets | Discovery |
| PPI Platform Programs | Undisclosed Oncology & Immunology Targets | Discovery |